The 2021 Hospital Price Transparency Rule required US hospitals to publish their prices publicly. Compliance remains below 25%, penalties are negligible ($300/day), and the data is often unusable. The rule proved that price variation in US healthcare is arbitrary — and that Colombia's all-inclusive packaging model is the transparent alternative Americans actually need.
On January 1, 2021, a rule took effect that was supposed to transform American healthcare: the Hospital Price Transparency Rule. For the first time, all US hospitals were required to publicly post their prices — including the negotiated rates they charge insurance companies, and the cash prices available to uninsured patients.
The theory was simple: if patients could see and compare prices, market forces would bring costs down. Three years later, the experiment has produced one clear finding — US hospital pricing is even more arbitrary than anyone suspected — and one clear failure: transparency alone doesn't fix a system built on opacity.
The Hospital Price Transparency Rule, issued by the Centers for Medicare & Medicaid Services (CMS), required every US hospital to publish two things:
A machine-readable file containing all items and services with their associated prices — including gross charges (chargemaster prices), discounted cash prices, and payer-specific negotiated rates for each insurer the hospital contracts with.
A consumer-friendly display of shoppable services — 300 common procedures with pricing in a format ordinary patients could understand.
Compliance was dismal. Multiple analyses found fewer than 25% of hospitals fully complied with both requirements. Many published files in obscure formats, buried the data behind multiple clicks, used internal codes instead of plain-language descriptions, or simply didn't post anything.
Enforcement was weak. The initial penalty was $300 per day for non-compliance — an annual maximum of $109,500. For a hospital billing hundreds of millions annually, that's not a penalty — it's a negligible cost of doing business. CMS has since increased penalties, but compliance has improved only incrementally.
The data that was published revealed stunning variation. Within the same city, the same procedure at similarly accredited hospitals varied by 300–500%. A knee MRI ranged from $200 to $3,500. Hip replacement surgery ranged from $14,000 to $75,000. There was no correlation between price and quality — higher prices didn't predict better outcomes.
Structural misalignment. US healthcare pricing isn't designed around patient choice. It's designed around insurer negotiation. Patients don't choose hospitals based on published prices — they choose based on their insurance network. The rule provided data that patients couldn't meaningfully act on.
Complexity by design. A single hospital can have hundreds of different negotiated rates for the same procedure — one for each insurer and plan type. A patient would need to know their specific plan, their remaining deductible, their coinsurance percentage, and whether the surgeon and anesthesiologist are both in-network to calculate an actual out-of-pocket cost. Published prices don't give you that.
No enforcement teeth. Without meaningful penalties, hospitals made a rational economic decision: the cost of transparency (potential competitive disadvantage, patient price-shopping, insurer renegotiation) exceeded the cost of non-compliance.
Colombia's medical tourism model is built on the exact transparency the US rule tried and failed to achieve. A typical Colombian surgical quote is all-inclusive: surgeon fee, anesthesia, facility, implants or materials, pre-op testing, post-op medications, and initial follow-up — one number, upfront, before you travel.
There's no chargemaster. No surprise billing. No separate bills from the surgeon, hospital, anesthesiologist, and pathologist arriving weeks later. No balance billing from out-of-network providers you never chose. One price, agreed to in advance, that covers the procedure from start to finish.
What transparency actually looks like: "Your rhinoplasty at [clinic name] will cost $3,200. That includes the surgeon, anesthesia, operating room, all medications, and three follow-up appointments. Flights and accommodation are separate." Compare that to a US experience where you might receive six separate bills over three months totaling an amount that bears no relationship to any number you were quoted beforehand.
The price transparency experiment didn't fail because transparency is a bad idea. It failed because it was applied to a system structurally designed around opacity. The chargemaster, balance billing, surprise bills, and multi-party billing are features, not bugs — they're how US hospital revenue models work.
For patients — especially the 100 million Americans carrying medical debt and the 4.8 million who've lost ACA coverage — the practical takeaway is clear: if price transparency matters to you, you'll find it abroad far more reliably than at home. Colombia's all-inclusive model isn't innovative — it's just honest pricing applied to healthcare.
Chargemaster Pricing Explained → Cost Comparison Table → Colombia Medical Hub →